General Western Blot Reagents
Abcam Native Chicken Deglycosylated Avidin protein (Cy3 ), 100UG
Native Chicken Deglycosylated Avidin protein (Cy3 ) is a Chicken Full Length protein, expressed in Native, with >95% purity and suitable for ELISA, WB, Flow Cyt.
Protein/ Peptide/ Enzyme Synonyms: Avidin, AVD
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam IBTP ((4-Iodobutyl)triphenylphosphonium), mitochondrial thiol-specific cationic alkylation reagent, 5MG
MW 572.2 Da, Purity >98%. Mitochondrial thiol-specific cationic alkylation reagent. Selective uptake into mitochondria leads to specific labelling of mitochondrial thiols. Can be used to identify thiol redox state. Cell-permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PR 619, DUB inhibitor, 25MG
MW 223.3 Da, Purity >99%. Cell-permeable, non-selective and reversible DUB inhibitor (IC₅₀ values are 5 to 20 μM). Induces polyubiquitinated protein accumulation in cells without directly affecting proteasome activity. Activates autophagy.
The product is subject to the following: Abcam Restricted Use Statement
Abcam trans-11-Methyl octadecenoate, 100MG
MW 296.5 Da, Purity >99%. Methyl ester of *trans*-11-octadecenoic acid. Possible insulinotropic effects. Use in lipid studies and as internal standard. See *trans*-11-octadecenoic acid (ab143923).
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Bisoprolol hemifumarate, beta1 antagonist, 50MG
MW 383.48 g/mol, Purity >99%. Selective β₁ antagonist (Ki = 22.4 nM). Antihypertensive agent.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Theanine (L-theanine), Amino acid analog of glutamine, 1G
MW 174.2 Da. Amino acid analog of glutamine, commonly found in green tea. Binds to AMPA, kainate, NMDA and group I mGlu receptors. Displays neuroprotective and cognitive enhancing effects. Also shown to modify self-renewal properties of cancer stem cells. Blood-brain barrier permeable and active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Voriconazole (UK-109, 496), anti-fungal agent, 10MG
MW 349.31 Da, Purity >99%. Potent and broad-spectrum anti-fungal agent. Inhibits CYP450-dependent 14-α sterol demethylase, to interfere with ergosterol biosynthesis and inhibit fungal growth. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pyocyanin, Catalase inhibitor, 5MG
MW 210.23 Da, Purity >98%. Catalase inhibitor. Aryl hydrocarbon receptor activator (Ki = 5.4 μM). Reduces gene expression of catalase. Promotes extracellular DNA release. Generates ROS. Induces apoptosis in neutrophils in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Betamethasone valerate, Glucocorticoid; immunomodulator, 100MG
MW 476.6 Da, Purity >98%. Glucocorticoid. Major steroid hormone. Anti-inflammatory and immunosuppresive effects. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Prostratin, PKC activator, 500UG
MW 390.48 g/mol. PKC activator; reactivates HIV-1 latency (IC₅₀ = ~0.5 μM) by PKC dependent NF-κB activation. Downregulates expression of HIV-1 receptor CD4 and its co-receptors CXCR4 and CCR5 in vitro. Non-tumor promoting.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Bisoprolol hemifumarate, beta1 antagonist, 10MG
MW 383.48 g/mol, Purity >99%. Selective β₁ antagonist (Ki = 22.4 nM). Antihypertensive agent.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Itraconazole, Cytochrome p450 inhibitor, 50MG
MW 705.64 g/mol, Purity >99%. Cytochrome p450 CYP3A4 inhibitor (IC₅₀ = 16-26 nM for midazolam hydroxylation). Higher affinity for fungal enzymes over mammalian cytochrome p450. Limited ability to cross the blood-brain barrier. Antifungal activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Deltamethrin, protein phosphatase 2B inhibitor, 50MG
MW 505.2 Da, Purity >98%. Potent protein phosphatase 2B inhibitor (IC₅₀ = 0.03 nM). Induces neurotoxicity by slowing the opening and closing of Na+ channels. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (S)-Propranolol hydrochloride, beta adrenoceptor antagonist, 100MG
MW 295.8 Da, Purity >98%. Non-selective β adrenoceptor antagonist. More active enantiomer of propranolol (ab120757).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mebendazole, Benzimidazole antihelmintic, 25G
MW 295.29 Da, Purity >99%. Benzimidazole antihelmintic. Tubulin-disrupting drug. Antitumour activity in vitro and in vivo. Inhibits growth and induces apoptosis.
The product is subject to the following: Abcam Restricted Use Statement